tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market
GYRE
Gyre Therapeutics
RESEARCH TOOLSreports

Gyre Therapeutics (GYRE) Stock News & Sentiment

827 Followers
Gyre Therapeutics Files NDA in China for F351
Premium
Company Announcements
Gyre Therapeutics Files NDA in China for F351
24d ago
8K
GYRE
Buy Rating on Gyre Therapeutics Driven by Priority Review of Hydronidone in China and De-Risked Path to 2026 Conditional Approval
Premium
Ratings
Buy Rating on Gyre Therapeutics Driven by Priority Review of Hydronidone in China and De-Risked Path to 2026 Conditional Approval
30d ago
GYRE
Gyre Therapeutics Faces Operational Risk From Rapid Shifts in Clinical Demand and Market Conditions
Premium
Company Announcements
Gyre Therapeutics Faces Operational Risk From Rapid Shifts in Clinical Demand and Market Conditions
1M ago
GYRE
Gyre Therapeutics Projects Strong Growth for Fibrosis Programs
Premium
Company Announcements
Gyre Therapeutics Projects Strong Growth for Fibrosis Programs
1M ago
8K
GYRE
Gyre Therapeutics to Acquire Cullgen in All-Stock Merger
Premium
Company Announcements
Gyre Therapeutics to Acquire Cullgen in All-Stock Merger
1M ago
8K
GYRE
Regulatory De-Risking and Priority Review for Hydronidone Underscore Upside in Gyre Therapeutics Shares
Premium
Ratings
Regulatory De-Risking and Priority Review for Hydronidone Underscore Upside in Gyre Therapeutics Shares
3M ago
GYRE
Gyre Therapeutics Advances Hydronidone Toward China Approval
Premium
Company Announcements
Gyre Therapeutics Advances Hydronidone Toward China Approval
3M ago
8K
GYRE
More GYRE News >

GYRE News on the Web

Gyre Therapeutics Files NDA in China for F351
TipRanks News
Neutral
Buy Rating on Gyre Therapeutics Driven by Priority Review of Hydronidone in China and De-Risked Path to 2026 Conditional Approval
TipRanks News
Bullish
Gyre Therapeutics’ liver fibrosis candidate granted priority review in China
TipRanks News
Bullish
Gyre Therapeutics Faces Operational Risk From Rapid Shifts in Clinical Demand and Market Conditions
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX) and Gyre Therapeutics (GYRE)
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Indivior (INDV), Gyre Therapeutics (GYRE)
TipRanks News
Bullish
Gyre Therapeutics Projects Strong Growth for Fibrosis Programs
TipRanks News
Neutral
Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates
Zacks
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GYRE’s Media Buzz Sentiment?
Currently, no data Available
What is GYRE’s weekly average amount of articles?
Currently, no data Available
What is GYRE’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
ALLOAllogene Therapeutics
TXTMProText Mobility
REPLReplimune Group
RVMDRevolution Medicines
TVTXTravere Therapeutics
Showing the stocks with the most bullish news sentiment over the past week